Results 121 to 130 of about 6,142 (164)

Concurrent Vibrio cholerae O1 Meningitis and Intracranial Lesions in a Patient With Sickle Cell Disease: A Case Report. [PDF]

Cureus
Alshuaibi TA, Althobaiti FA, Youldash OA, Shati RO, Alamri B.   +4 more
europepmc   +1 more source

Human antibody targeting <i>Vibrio cholerae</i> O1 O-specific polysaccharide induces an amotile hypovirulent bacterial phenotype: mechanism of protection against cholera. [PDF]

mBio
Verma S, Cetinbas M, Kelly M, Senger S, Faherty CS, Janardhanan J, Wagh CR, Bhuiyan TR, Chowdhury F, Khan AI, Akter A, Charles RC, Harris JB, Calderwood SB, Wrammert J, Waldor MK, Asp M, Tai J-SB, Yan J, Xu P, Kováč P, Sadreyev RI, Qadri F, Ryan ET.   +23 more
europepmc   +1 more source

Environmental prevalence of toxigenic Vibrio cholerae O1 in Bangladesh coincides with V. cholerae non-O1 non-O139 genetic variants which overproduce autoinducer-2. [PDF]

PLoS One, 2021
Naser IB, Shishir TA, Faruque SN, Hoque MM, Hasan A, Faruque SM.   +5 more
europepmc   +1 more source

Vibriocidal efficacy of Bifidobacterium bifidum and Lactobacillus acidophilus cell-free supernatants encapsulated in chitosan nanoparticles against multi-drug resistant Vibrio cholerae O1 El Tor. [PDF]

BMC Infect Dis
Derakhshan-Sefidi M, Bakhshi B, Rasekhi A.   +2 more
europepmc   +1 more source

Genomic analysis of Vibrio cholerae O1 isolates from cholera cases, Europe, 2022. [PDF]

Euro Surveill
Rouard C, Greig DR, Tauhid T, Dupke S, Njamkepo E, Amato E, van der Putten B, Naseer U, Blaschitz M, Mandilara GD, Cohen Stuart J, Indra A, Noël H, Sideroglou T, Heger F, van den Beld M, Wester AL, Quilici ML, Scholz HC, Fröding I, Jenkins C, Weill FX.   +21 more
europepmc   +1 more source

Outbreak of <i>Vibrio cholerae</i>, Mayotte, France, April to July 2024. [PDF]

Euro Surveill
Mazzilli S, Youssouf H, Durand J, Soler M, Cholin T, Herry F, Collet L, Jean M, Ransay-Colle M, Benoit-Cattin T, Rouard C, Figoni J, Noël H, Piarroux R, Lapostolle A.   +14 more
europepmc   +1 more source

Use of a MAIT-Activating Ligand, 5-OP-RU, as a Mucosal Adjuvant in a Murine Model of Vibrio cholerae O1 Vaccination. [PDF]

Pathog Immun, 2022
Jensen O, Trivedi S, Li K, Aubé J, Hale JS, Ryan ET, Leung DT.   +6 more
europepmc   +1 more source

Emergence of multidrug resistant, ctx negative seventh pandemic Vibrio cholerae O1 El Tor sequence type (ST) 69 in coastal water of Kerala, India. [PDF]

Sci Rep
Ayyappan MV, Kishore P, Panda SK, Kumar A, Uchoi D, Nadella RK, Priyadarshi H, Obaiah MC, George D, Hamza M, Ramannathan SK, Ravishankar CN.   +11 more
europepmc   +1 more source

Emergence of Vibrio cholerae O1 Sequence Type 75 in Taiwan. [PDF]

Emerg Infect Dis, 2020
Tu YH, Chen BH, Hong YP, Liao YS, Chen YS, Liu YY, Teng RH, Wang YW, Chiou CS.   +8 more
europepmc   +1 more source

Field Evaluation of Cholkit Rapid Diagnostic Test for Vibrio Cholerae O1 During a Cholera Outbreak in Malawi, 2018. [PDF]

Open Forum Infect Dis, 2020
Chibwe I, Kasambara W, Kagoli M, Milala H, Gondwe C, Azman AS.   +5 more
europepmc   +1 more source